Investor conference call for Q2-FY27 is scheduled to be held on 05 November 2026.

Shilpa Medicare Limited Corporate & Admin Office: “Shilpa House”, # 12-6-214/A-1, Hyderabad Road, Raichur – 584 135, Karnataka, India Tel: +91-8532-238704, Fax: +91-8532-238876 Email: info@vbshilpa.com, Web: www.vbshilpa.com CIN: L85110KA1987PLC008739 Date: 29 October 2026 Corporate Relationship Department, National Stock Exchange of India Limited BSE Limited Exchange Plaza, 5th Floor, Phiroze Jeejeebhoy Towers, Plot No.C/1, G Block Dalal Street, Fort, Bandra Kurla Complex, Bandra (E) Mumbai-400 001 Mumbai-400 051 Dear Madam/Sir, Sub: Analysts/Investors call Ref: Stock Code: NSE: SHILPAMED/BSE-530549 Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the schedule of Q2- FY27 Earnings Conference Call, is scheduled to be held on Thursday, 5 November 2026, at 16.00 hrs. A copy of this intimation is also being made available at: https://www.vbshilpa.com/investor-presentation.php We request you to take the above information on record. Thanking you. Yours faithfully, For Shilpa Medicare Limited Ritu Tiwary Company Secretary Shilpa Medicare Limited 2QFY27 Earnings Conference Call Shilpa Medicare Limited (BSE:530549; NSE: SHILPAMED)will announceits results for the quarter and half year ended September 30, 2026, on Thursday, November 05, 2026 Themanagement of the Company will host its earningscall on Thursday, November 05, 2026at 16:00 hrs IST Details of Earnings Conference Call Day/Date Thursday, November 05, 2026 Time 16:00 hrs IST Universal Access +91 22 6280 1130 +91 22 7115 8031 The numbers listed above is universally accessible from all networks and all countries International Toll-Free Numbers USA 18667462133 UK 08081011573 Singapore 8001012045 Hong Kong 800964448 DiamondPass Link Click here to join with DiamondPass (No Wait Time) Participants are requested to dial-in 10 minutes before the scheduled time About Shilpa Medicare Limited (SML) Shilpa Medicare Limited is a research-driven and vertically integrated pharmaceutical company, headquartered in Raichur, India. Guided by its purpose of Bringing Complex Molecules to Medicines, the Company combines scientific and manufacturing expertise across high-potency oncology APIs, Peptides, Complex Injectables, Novel Drug Delivery Systems, Biologics, NBEs and CDMO services. Its manufacturing facilities are approved by international regulatory authorities, and it serves partners and patients across the United States, Europe, Japan, MENA region, and other large international markets. Shilpa Medicare is committedtomakinghigh-qualitymedicinesmoreaccessibleworldwide. For more information, visit www.vbshilpa.com Forfurtherdetails,pleasegetintouchwith ShilpaMedicareLtd MonishShah E: monish.shah@vbshilpa.com